Espinosa-Jeffrey Araceli, Blanchi Bruno, Biancotti Juan Carlos, Kumar Shalini, Hirose Megumi, Mandefro Berhan, Talavera-Adame Dodanim, Benvenisty Nissim, de Vellis Jean
Intellectual and Developmental Disabilities Research Center, Semel Institute for Neuroscience, David Geffen School of Medicine at UCLA, Los Angeles, California.
Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California.
Curr Protoc Stem Cell Biol. 2016 Aug 17;38:2D.18.1-2D.18.27. doi: 10.1002/cpsc.11.
Here we document three highly reproducible protocols: (1) a culture system for the derivation of human oligodendrocytes (OLs) from human induced pluripotent stem cells (hiPS) and their further maturation-our protocol generates viral- and integration-free OLs that efficiently commit and move forward in the OL lineage, recapitulating all the steps known to occur during in vivo development; (2) a method for the isolation, propagation and maintenance of neural stem cells (NSCs); and (3) a protocol for the production, isolation, and maintenance of OLs from perinatal rodent and human brain-derived NSCs. Our unique culture systems rely on a series of chemically defined media, specifically designed and carefully characterized for each developmental stage of OL as they advance from OL progenitors to mature, myelinating cells. We are confident that these protocols bring our field a step closer to efficient autologous cell replacement therapies and disease modeling. © 2016 by John Wiley & Sons, Inc.
在此,我们记录了三种高度可重复的方案:(1)一种从人诱导多能干细胞(hiPS)中衍生出人少突胶质细胞(OLs)并使其进一步成熟的培养系统——我们的方案可产生无病毒且无整合的OLs,这些OLs能有效地在OL谱系中定向分化并向前发展,重现了体内发育过程中已知发生的所有步骤;(2)一种分离、增殖和维持神经干细胞(NSCs)的方法;以及(3)一种从围产期啮齿动物和人脑源性NSCs中生产、分离和维持OLs的方案。我们独特的培养系统依赖于一系列化学成分明确的培养基,这些培养基是针对OL从祖细胞发育为成熟的髓鞘形成细胞的每个发育阶段专门设计并经过仔细表征的。我们相信,这些方案使我们的领域朝着高效的自体细胞替代疗法和疾病建模又迈进了一步。© 2016约翰威立国际出版公司